Skip to main content

ANTIPODES PARTNERS Ltd

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1652442 ROYAL EXCHANGE, C3

Position in ALNY

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$49,228,338
+$1,149,619 QoQ
Shares Held
163,533
+12.5% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#84
of 784 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ANTIPODES PARTNERS Ltd holds $60,434,232 across 11 Biotechnology names. ALNY ranks #1 (81.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
This page
163,533 $49,228,338

All Filings in ALNY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,228,338 163,533
2026-03-31 $48,078,719 145,310
2025-12-31 $19,041,867 47,886
2025-09-30 $14,571,936 31,956
2025-06-30 $40,045,156 122,804
2025-03-31 $43,082,771 159,554
2024-12-31 $31,474,830 133,759
2024-09-30 $38,332,306 139,375
2024-06-30 $58,016,007 238,749
2024-03-31 $30,723,781 205,579
2023-12-31 $36,203,478 189,141
2023-09-30 $19,805,801 111,834
2023-06-30 $10,636 56
2023-03-31 $28,044 140
2022-12-31 $28,042 118